Privia Health [PRVA] vs Ge Healthcare [GEHC] Detailed Stock Comparison
Privia Health
NASDAQ
Loading...
Ge Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Privia Health wins in 5 metrics, Ge Healthcare wins in 14 metrics, with 0 ties. Ge Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Privia Health | Ge Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 192.00 | 15.04 | Ge Healthcare |
| Price-to-Book Ratio | 3.79 | 3.45 | Ge Healthcare |
| Debt-to-Equity Ratio | 0.91 | 107.67 | Privia Health |
| PEG Ratio | 81.23 | 1.18 | Ge Healthcare |
| EV/EBITDA | 79.67 | 11.09 | Ge Healthcare |
| Profit Margin (TTM) | 0.78% | 11.22% | Ge Healthcare |
| Operating Margin (TTM) | 0.64% | 14.62% | Ge Healthcare |
| EBITDA Margin (TTM) | 0.64% | 14.62% | Ge Healthcare |
| Return on Equity | 2.71% | 25.80% | Ge Healthcare |
| Return on Assets (TTM) | 1.04% | 5.77% | Ge Healthcare |
| Free Cash Flow (TTM) | $109.28M | $1.55B | Ge Healthcare |
| Dividend Yield | N/A | 0.24% | N/A |
| 1-Year Return | 6.88% | -13.44% | Privia Health |
| Price-to-Sales Ratio (TTM) | 1.36 | 1.68 | Privia Health |
| Enterprise Value | $2.21B | $40.73B | Ge Healthcare |
| EV/Revenue Ratio | 1.16 | 2.04 | Privia Health |
| Gross Profit Margin (TTM) | 9.64% | 39.65% | Ge Healthcare |
| Revenue per Share (TTM) | $16 | $44 | Ge Healthcare |
| Earnings per Share (Diluted) | $0.11 | $4.88 | Ge Healthcare |
| Beta (Stock Volatility) | 0.81 | 1.28 | Privia Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Privia Health vs Ge Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Privia Health | 2.70% | 3.35% | 3.05% | -14.58% | -15.06% | 8.30% |
| Ge Healthcare | -0.35% | 1.94% | -1.33% | 0.67% | -20.79% | -6.35% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Privia Health | 6.88% | -41.71% | -41.44% | -41.44% | -41.44% | -41.44% |
| Ge Healthcare | -13.44% | 29.36% | 29.36% | 29.36% | 29.36% | 29.36% |
Performance & Financial Health Analysis: Privia Health vs Ge Healthcare
| Metric | PRVA | GEHC |
|---|---|---|
| Market Information | ||
| Market Cap | $2.59B | $33.51B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 1,278,308 | 3,499,300 |
| 90 Day Avg. Volume | 976,666 | 3,975,303 |
| Last Close | $21.27 | $73.40 |
| 52 Week Range | $16.47 - $26.09 | $57.65 - $94.80 |
| % from 52W High | -18.47% | -22.57% |
| All-Time High | $50.77 (Jun 28, 2021) | $94.80 (Feb 10, 2025) |
| % from All-Time High | -58.11% | -22.57% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.23% | 0.04% |
| Quarterly Earnings Growth | -0.23% | 0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.11% |
| Operating Margin (TTM) | 0.01% | 0.15% |
| Return on Equity (TTM) | 0.03% | 0.26% |
| Debt to Equity (MRQ) | 0.91 | 107.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.57 | $21.27 |
| Cash per Share (MRQ) | $3.18 | $8.19 |
| Operating Cash Flow (TTM) | $91.86M | $2.00B |
| Levered Free Cash Flow (TTM) | $92.29M | $1.58B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.24% |
| Last 12-Month Dividend | $0.00 | $0.18 |
Valuation & Enterprise Metrics Analysis: Privia Health vs Ge Healthcare
| Metric | PRVA | GEHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 192.00 | 15.04 |
| Forward P/E | 81.23 | 15.72 |
| PEG Ratio | 81.23 | 1.18 |
| Price to Sales (TTM) | 1.36 | 1.68 |
| Price to Book (MRQ) | 3.79 | 3.45 |
| Market Capitalization | ||
| Market Capitalization | $2.59B | $33.51B |
| Enterprise Value | $2.21B | $40.73B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.16 | 2.04 |
| Enterprise to EBITDA | 79.67 | 11.09 |
| Risk & Other Metrics | ||
| Beta | 0.81 | 1.28 |
| Book Value per Share (MRQ) | $5.57 | $21.27 |
Financial Statements Comparison: Privia Health vs Ge Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PRVA | GEHC |
|---|---|---|
| Revenue/Sales | $480.10M | $4.78B |
| Cost of Goods Sold | $434.34M | $2.77B |
| Gross Profit | $45.76M | $2.01B |
| Research & Development | N/A | $344.00M |
| Operating Income (EBIT) | $5.22M | $628.00M |
| EBITDA | $7.12M | $842.00M |
| Pre-Tax Income | $8.15M | $692.00M |
| Income Tax | $2.10M | $104.00M |
| Net Income (Profit) | $6.05M | $588.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PRVA | GEHC |
|---|---|---|
| Cash & Equivalents | $469.33M | $2.45B |
| Total Current Assets | $886.47M | $9.74B |
| Total Current Liabilities | $470.81M | $9.97B |
| Long-Term Debt | $3.05M | $7.06B |
| Total Shareholders Equity | $709.53M | $9.42B |
| Retained Earnings | $-175.01M | $3.81B |
| Property, Plant & Equipment | $1.01M | $369.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PRVA | GEHC |
|---|---|---|
| Operating Cash Flow | $-9.30M | $509.00M |
| Capital Expenditures | N/A | $-152.00M |
| Free Cash Flow | $-24.06M | $98.00M |
| Debt Repayment | N/A | $-257.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PRVA | GEHC |
|---|---|---|
| Shares Short | 3.25M | 9.02M |
| Short Ratio | 3.70 | 2.31 |
| Short % of Float | 0.05% | 0.03% |
| Average Daily Volume (10 Day) | 1,278,308 | 3,499,300 |
| Average Daily Volume (90 Day) | 976,666 | 3,975,303 |
| Shares Outstanding | 120.31M | 456.96M |
| Float Shares | 104.96M | 455.36M |
| % Held by Insiders | 0.07% | 0.00% |
| % Held by Institutions | 1.00% | 0.87% |
Dividend Analysis & Yield Comparison: Privia Health vs Ge Healthcare
| Metric | PRVA | GEHC |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $0.18 |
| Last 12-Month Dividend Yield | N/A | 0.24% |
| 3-Year Avg Annual Dividend | $0.05 | $0.11 |
| 3-Year Avg Dividend Yield | 0.18% | 0.04% |
| 3-Year Total Dividends | $0.15 | $0.33 |
| Ex-Dividend Date | Mar 28, 2023 | Jul 25, 2025 |